At Janssen, the pharmaceutical companies of Johnson & Johnson, our vision is a world free from immune diseases. To achieve this, we will translate internal and external science to deliver products that treat, prevent, intercept, and cure immune-mediated diseases.
We are committed to the
FUTURE OF IMMUNOLOGY
At Janssen, the pharmaceutical companies of Johnson & Johnson, our mission is to transform individual lives and fundamentally change the way diseases are managed, interpreted, and prevented.
Commitment to the Future of Immunology1-44
For investigational agents or investigational uses of
products, the safety and efficacy have not been determined. There is no guarantee that the
investigational agents listed will be filed with and/or approved for marketing by the FDA.
For additional information, you may visit www.clinicaltrials.gov.
AS, ankylosing spondylitis; CD, Crohn's disease; FAP, familial adenomatous polyposis; GCA, giant cell arteritis; IIM, idiopathic inflammatory myopathies; LN, lupus nephritis; Ph, phase; PJIA, polyarticular juvenile idiopathic arthritis; PsA, psoriatic arthritis; PsO, psoriasis; pSS, primary Sjögren's syndrome; RA, rheumatoid arthritis; RWE, real-world evidence; SLE, systemic lupus erythematosus; SS, systemic sclerosis; UC, ulcerative colitis.
Timeline years correspond to the date when study recruitment opened. Current as of July 2023.
- Maini RN, et al. Arthritis Rheum. 1998;41(9):1552-1563.
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT00269867
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT00236028
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT00036387
- Antoni C, et al. Ann Rheum Dis. 2005;64;1150-1157
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT00207701
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT00264537
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT00264550
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT00265083
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT00265096
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT00267956
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT00299546
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT00361335
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT00508547
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT01004432
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT00973479
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT01009086
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT01077362
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT02277444
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT02186873
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT02181673
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT02319759
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT02349061
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT02627768
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT02728934
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT03162796
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT03158285
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT03649971
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT04376827
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT04633447
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT04991753
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT04882098
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT04929210
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT04936308
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT04968912
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT04882878
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT04883619
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT05071664
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT05092269
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT05004727
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT05379634
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT05252533
- ClinicalTrials.gov. Accessed July 14, 2023. https://clinicaltrials.gov/ct2/show/NCT05083182
- ClinicalTrials.gov. Accessed July 14, 2023. https://classic.clinicaltrials.gov/ct2/show/NCT05669833
© Janssen Biotech, Inc. 2023 08/23 cp-344367v3
© Janssen Biotech, Inc. 2023. All rights reserved.
cp-182260v8
This site is published by Janssen Biotech, Inc., which is solely responsible for its contents. This site is intended for use by healthcare professionals of the United States and Puerto Rico. Janssen Biotech, Inc., recognizes that the Internet is a global communications medium; however, laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing Information that may be included here may not be appropriate for use outside the United States and Puerto Rico.
Third-party trademarks used herein are trademarks of their respective owners.
You are now entering the medical affairs booth (microsite). Travel between the promotional and medical affairs booth is prohibited.
Medical Inquiries
United States
Healthcare professionals, patients, or caregivers in the United States may contact the Medical Information Center by visiting www.askjanssenmedinfo.com or by calling 1‑800‑JANSSEN (1‑800‑526‑7736) to speak to a clinical expert regarding their question or to report a possible adverse event or product quality complaint.
Healthcare professionals in the United States may also contact their local Medical Science Liaison (MSL) by visiting www.JanssenMSL.com. MSLs are scientific and healthcare professionals that are available to respond via phone, email, or in person to clinical and scientific inquiries.
Outside of the United States
If you are seeking medical information or would like to report an Adverse Event (medication side effect) or Product Quality Complaint (problem with one of our products), please use the email address for the country where you are located. View this PDF for country‑specific information.
